Imiquimod 5% cream in topical treatment of facial basal cell carcinoma
Introduction: Basal Cell Carcinoma (BCC) is a non-melanocytic skin neoplasm originating from the cells in the basal epidermal layer, hair follicle shell or other skin adnexa. It is the most frequent skin malignancy. Treatment is surgical or nonsurgical. Cases reports: Herein we present 2 patients wi...
Main Authors: | Grubor Svetlana D., Tatljak-Vlahović Vesna J., Radojević Biljana P. |
---|---|
Format: | Article |
Language: | English |
Published: |
Srpsko lekarsko drustvo
2015-01-01
|
Series: | Hospital Pharmacology |
Subjects: | |
Online Access: | http://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2015/2334-94921501184G.pdf |
Similar Items
-
Imiquimod 5% Cream for Treatment of Actinic Keratosis of the Eyelid
by: Gamze Ozturk Karabulut, et al.
Published: (2017-05-01) -
Topical Treatments for Basal Cell Carcinoma and Actinic Keratosis in the United States
by: Isabella J. Tan, et al.
Published: (2023-08-01) -
Lichenoid keratosis successfully treated with topical imiquimod
by: Hessah BinJadeed, MD, et al.
Published: (2020-12-01) -
Successful treatment of giant basal cell carcinoma with topical imiquimod 5% cream with long term follow-up
by: M Chun-Guang, et al.
Published: (2014-01-01) -
Superficial basal cell carcinoma treated with curettage followed by topical imiquimod cream: A retrospective study
by: Andrew L. Ondo, MD, et al.
Published: (2024-03-01)